TherapeuticsMD (TXMD) Stock Chart & Stock Price History $1.45 0.00 (0.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.44 -0.01 (-0.69%) As of 05/23/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TherapeuticsMD Stock Price Performance The TherapeuticsMD (TXMD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 32.24%, with a year-to-date return of 68.60%. In the past month, the stock has increased 27.19%, reflecting recent market activity. As of the latest close, TherapeuticsMD traded at $1.45 with a market cap of $16.78 million and volume of 14,087 shares. Five years ago, the stock traded at a split-adjusted price of $62.50, representing a 97.68% decrease over that period. At the time, it had a market cap of $323.30 million and a volume of 8.93 million shares. Receive TXMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.03%1 Month Performance+27.19%3 Month Performance+45.00%Year-To-Date Performance+68.60%1 Year Performance-32.24%5 Year Performance-97.68% TXMD Stock Chart for Saturday, May, 24, 2025 TXMD Chart by TradingView TherapeuticsMD Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$1.45$1.45$1.49$1.4214,087 shs$16.78 million05/22/2025$1.46$1.45-0.68%$1.51$1.4113,120 shs$16.78 million05/21/2025$1.49$1.46-2.01%$1.50$1.4216,447 shs$16.90 million05/20/2025$1.48$1.49+0.68%$1.49$1.4611,016 shs$17.25 million05/19/2025$1.50$1.48-1.33%$1.53$1.4744,068 shs$17.13 million05/16/2025$1.46$1.50+2.74%$1.52$1.4243,461 shs$17.36 million05/15/2025$1.46$1.46$1.50$1.407,311 shs$16.90 million05/14/2025$1.52$1.46-3.95%$1.54$1.4623,142 shs$16.90 million05/13/2025$1.48$1.52+2.70%$1.52$1.4832,549 shs$17.59 million05/12/2025$1.46$1.48+1.37%$1.53$1.4635,590 shs$17.13 million Get the Latest News and Ratings for TXMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$1.40$1.46+4.29%$1.47$1.4022,785 shs$16.90 million05/08/2025$1.38$1.40+1.25%$1.47$1.3539,626 shs$16.20 million05/07/2025$1.41$1.38-1.94%$1.45$1.3813,981 shs$16.00 million05/06/2025$1.43$1.41-1.05%$1.46$1.4121,570 shs$16.32 million05/05/2025$1.42$1.43+0.35%$1.54$1.32112,872 shs$16.49 million05/02/2025$1.39$1.42+2.16%$1.47$1.3585,459 shs$16.44 million05/01/2025$1.24$1.39+12.10%$1.48$1.25191,578 shs$16.09 million04/30/2025$1.23$1.24+0.81%$1.27$1.2034,614 shs$14.35 million04/29/2025$1.22$1.23+0.82%$1.24$1.1649,060 shs$14.24 million04/28/2025$1.15$1.22+6.09%$1.23$1.1149,253 shs$14.12 million04/25/2025$1.14$1.15+0.88%$1.18$1.0855,273 shs$13.31 million04/24/2025$1.08$1.14+5.56%$1.14$1.0632,057 shs$13.19 million04/23/2025$1.11$1.08-2.70%$1.15$1.0156,587 shs$12.85 million Related Companies Biomea Fusion Stock Price Chart Applied Therapeutics Stock Price Chart Cabaletta Bio Stock Price Chart Medicus Pharma Stock Price Chart ZIVO Bioscience Stock Price Chart Vistagen Therapeutics Stock Price Chart Milestone Pharmaceuticals Stock Price Chart Citius Oncology Stock Price Chart Acumen Pharmaceuticals Stock Price Chart Skye Bioscience Stock Price Chart Receive TXMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TXMD) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe “black glass” breakthrough behind AI’s next leapAI is advancing fast… But there’s one problem almost no one’s talking about. Power.True Market Insiders | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.